β-elemene reverses chemoresistance of breast cancer via regulating MDR-related MicroRNA expression

Cellular Physiology and Biochemistry

Volumn 34, Issue 6, 2014, Pages 2027-2037

  Zhang, Jun ^a,c,e   Da Zhang, He ^a,b   Chen, Lin ^a,b   Sun, Da Wei ^a,d   Mao, Chang Fei ^a   Chen, Wei ^a,b   Wu, Jian Zhong ^a   Zhong, Shan Liang ^a   Zhao, Jian Hua ^a   Tang, Jin Hai ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e NANJING UNIVERSITY   (China)

Author keywords

Breast cancer; Chemoresistance; miRNA; elemene

Indexed keywords

BETA ELEMENE; DOCETAXEL; DOXORUBICIN; LUCIFERASE; MICRORNA; MICRORNA 222; MICRORNA 29A; MICRORNA 34A; MICRORNA 452; UNCLASSIFIED DRUG; ELEMENE; MIRN222 MICRORNA, HUMAN; MIRN29 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN; MIRN452 MICRORNA, HUMAN; SESQUITERPENE; TAXOID;

ARTICLE; BREAST CANCER; CELL SURVIVAL; COMPARATIVE STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; SESQUITERPENES; TAXOIDS;

EID: 84920888951     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366398     Document Type: Article

References (22)

1. Li QQ, Wang G, Reed E, Huang L, Cuff CF: Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol 2010;107:868-876
2. Zhang X, Zhang Y, Li Y:elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells. Oncol Rep 2013;30:745-750
3. Xu HB, Li L, Fu J, Mao XP, Xu LZ: Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene. Pharmacology 2012;89:303-312
4. Guo HQ, Zhang GN, Wang YJ, Zhang YK, Sodani K, Talele TT, Ashby CR Jr, Chen ZS: Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter. Oncol Rep 2014;31:858-866
5. Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K: MiRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome. J Mol Diagn 2013;15:695-705
6. Chen WX, Hu Q, Qiu MT, Zhong SL, Xu JJ, Tang JH, Zhao JH: MiR-221/222: promising biomarkers for breast cancer. Tumour Biol 2013;34:1361-1370
7. Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C: A Common MicroRNA Signature Consisting of miR-133a, miR-139-3p, and miR-142-3p Clusters Bladder Carcinoma in Situ with Normal Umbrella Cells. Am J Pathol 2013;182:1171-1179
8. Kutanzi KR, Yurchenko OV, Beland FA, Checkhun VF, Pogribny IP: MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2011;2:171-185
9. Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M: MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Res Treat Cancer Breast 2013;139:717-730
10. Zhong S, Li W, Chen Z, Xu J, Zhao J: MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.Gene 2013;531:8-14
11. Li XJ, Ji MH, Zhong SL, Zha QB, Xu JJ, Zhao JH, Tang JH: MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Arch Med Res 2012;43:514-521
12. Zhang Y, Mu XD, Li EZ: The Role of E3 Ubiquitin Ligase Cbl Proteins in β-Elemene Reversing Multi-Drug Resistance of Human Gastric Adenocarcinoma Cells. Int J Mol Sci 2013;14: 0075-10089
13. Yang L, Li N, Wang H, Jia X, Wang X, Luo J: Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drugresistance. OncolRep 2012;28:592-600
14. Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, Nie Y, Wu K, Shi Y, Fan D: MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun 2013;434:688-694
15. Zhang X, Li Y, Zhang Y, Song J, Wang Q, Zheng L, Liu D: Beta-elemene blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors. PLOS One 2013;8:e58719
16. Ding XF, Shen M, Xu LY: 13, 14-bis (cis-3, 5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cells. Oncol Lett 2013;5:1554-1558
17. Lu X, Wang Y, Luo H, Qiu W, Han H, Chen X, Yang L: β-elemene inhibits the proliferation of T24 bladder carcinoma cells through upregulation of the expression of Smad4. Mol Med Rep 2013;7:513-518
18. Lee RX, Li QQ, Reed E: Elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res 2012;32:3103-3113
19. Zhang Y, Mu XD, Li EZ: The Role of E3 Ubiquitin Ligase Cbl Proteins in β-Elemene Reversing Multi-Drug Resistance of Human Gastric Adenocarcinoma Cells. Int J Mol Sci 2013;10:10075-10089
20. Li QQ, Lee RX, Liang H, Wang G, Li JM, Zhong Y, Reed E: β-elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK. Int J Oncol 2013;43:721-728
21. Yao CC, Tu YR, Jiang J, Ye SF, Du HX, Zhang Y: β-elemene reverses the drug resistance of lung cancer A549/ DDP cells via the mitochondrial apoptosis pathway. Oncol Rep 2014;31:2131-2138
22. Zhang B, Zhang X, Tang B, Zheng P, Zhang Y: Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor a (ERa) re-expression. Breast Cancer Res Treat 2012;136:399-406